Codexis (CDXS) News Today → Did you make $29,000 two days with AI options trades? (From Prosper Trading Academy) (Ad) Free CDXS Stock Alerts $3.25 -0.08 (-2.40%) (As of 03/18/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineGSA Capital Partners LLP Invests $786,000 in Codexis, Inc. (NASDAQ:CDXS)marketbeat.com - March 12 at 6:59 AMFmr LLC Boosts Position in Codexis, Inc. (NASDAQ:CDXS)marketbeat.com - March 8 at 4:25 AMFederated Hermes Inc. Decreases Stake in Codexis, Inc. (NASDAQ:CDXS)marketbeat.com - March 2 at 5:46 AMBenchmark raises Codexis to buy; cites Q4 earnings, guidancemsn.com - March 1 at 6:57 PMBenchmark Upgrades Codexis (CDXS)msn.com - March 1 at 8:56 AMStifel Nicolaus Keeps Their Buy Rating on Codexis (CDXS)markets.businessinsider.com - February 29 at 2:56 PMCodexis, Inc. (NASDAQ:CDXS) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - February 29 at 2:56 PMCodexis, Inc.: Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Resultsfinanznachrichten.de - February 29 at 9:55 AMQ4 2023 Codexis Inc Earnings Callfinance.yahoo.com - February 29 at 9:55 AMCodexis (NASDAQ:CDXS) Raised to "Buy" at Benchmarkmarketbeat.com - February 29 at 9:47 AMRecap: Codexis Q4 Earningsbenzinga.com - February 28 at 7:23 PMCodexis GAAP EPS of -$0.10 beats by $0.04, revenue of $26.56M beats by $7.63Mmsn.com - February 28 at 7:23 PMCodexis Inc (CDXS) Reports Fiscal Year 2023 Financial Resultsfinance.yahoo.com - February 28 at 7:23 PMCodexis Reports Fourth Quarter and Fiscal Year 2023 Financial Resultsglobenewswire.com - February 28 at 4:05 PMBiotech Rallied Strongly On Exclusive Licensing Agreementtheglobeandmail.com - February 28 at 8:54 AMCodexis Shares Up 31% on Roche Licensing Agreementmarketwatch.com - February 27 at 2:43 PMCodexis Q4 2023 Earnings Previewmsn.com - February 27 at 2:43 PMCodexis, Inc. (NASDAQ:CDXS) Position Increased by Acadian Asset Management LLCmarketbeat.com - February 27 at 6:02 AMCodexis stock climbs 11% on Roche licensing deal for DNA ligasesmsn.com - February 26 at 7:35 PMCodexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Rocheglobenewswire.com - February 26 at 4:05 PMCodexis to Participate in TD Cowen 44th Annual Health Care Conferenceglobenewswire.com - February 26 at 8:05 AMCodexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory Boardfinance.yahoo.com - February 20 at 1:49 PMCodexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory Boardglobenewswire.com - February 20 at 8:05 AMCodexis, Inc. (NASDAQ:CDXS) Shares Sold by Baillie Gifford & Co.marketbeat.com - February 17 at 9:19 AMCodexis Inc.money.usnews.com - February 16 at 6:36 PMCodexis to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 28globenewswire.com - February 14 at 4:05 PMCodexis (NASDAQ:CDXS) Shares Pass Above 200-Day Moving Average of $2.25marketbeat.com - February 14 at 3:19 AMCodexis, Inc. (NASDAQ:CDXS) Given Average Recommendation of "Moderate Buy" by Brokeragesmarketbeat.com - February 5 at 3:20 AMCodexis, Inc. (NASDAQ:CDXS) Shares Sold by Allspring Global Investments Holdings LLCmarketbeat.com - February 3 at 4:15 AMKLIC, CLFD and CDXS are among after hour moversmsn.com - February 2 at 12:58 PMAssenagon Asset Management S.A. Has $3.31 Million Stake in Codexis, Inc. (NASDAQ:CDXS)marketbeat.com - February 2 at 5:40 AMCodexis (NASDAQ:CDXS) Share Price Crosses Above 200 Day Moving Average of $2.30marketbeat.com - February 2 at 3:14 AMseqWell and Codexis to Unveil Engineered Transposase Enzyme for Genomics Applications at AGBT General Meetingfinance.yahoo.com - February 1 at 8:51 PMShort Interest in Codexis, Inc. (NASDAQ:CDXS) Drops By 13.7%marketbeat.com - January 16 at 1:31 PMThe past three years for Codexis (NASDAQ:CDXS) investors has not been profitablefinance.yahoo.com - January 14 at 9:55 AMBaillie Gifford Trims Position in Codexis Incgurufocus.com - January 8 at 7:05 PMCodexis Inks Purchase Deal With Nestle Health Science For CDX-7108markets.businessinsider.com - December 27 at 1:37 PMCodexis Clinches Deal With Nestlé Health Science, Eyes Up To $45M Milestone In EPI Treatment Breakthroughmsn.com - December 27 at 1:37 PMCodexis, Inc. (NASDAQ:CDXS) Stock Rockets 41% But Many Are Still Ignoring The Companyfinance.yahoo.com - December 18 at 10:09 AMCodexis, Inc. (NASDAQ:CDXS) Short Interest Updatemarketbeat.com - December 17 at 3:58 PMCodexis, Inc.; Aldevron: Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex HiCap RNA Polymerasefinanznachrichten.de - December 14 at 10:36 AMCodexis Shares Rise 19% on Licensing Agreement with Aldevronmarketwatch.com - December 14 at 10:36 AMCodexis Announces Achievement of Gram-scale Synthesis with its ECO Synthesis™ Platformfinance.yahoo.com - December 13 at 5:50 PMCodexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA Polymerasefinance.yahoo.com - December 13 at 5:50 PMCodexis KOL Event Highlights Significant Need for an Enzymatic Route of Synthesis in RNAi Therapeutics Manufacturingfinance.yahoo.com - December 11 at 7:17 AMAnalysts Offer Insights on Healthcare Companies: REPRO-MED Systems (KRMD) and Codexis (CDXS)markets.businessinsider.com - December 7 at 6:17 PMCodexis, Inc.'s (NASDAQ:CDXS) Intrinsic Value Is Potentially 92% Above Its Share Pricefinance.yahoo.com - November 30 at 7:51 AMCodexis to Host Virtual KOL Event on its ECO Synthesis™ Platform and the Future of RNAi Therapeutics Manufacturing on December 8, 2023finance.yahoo.com - November 28 at 7:00 PMCodexis to Participate in 35th Annual Piper Sandler Healthcare Conferencefinance.yahoo.com - November 14 at 8:18 PMCodexis, Inc. (NASDAQ:CDXS) is largely controlled by institutional shareholders who own 74% of the companyfinance.yahoo.com - November 13 at 8:17 AM Get Codexis News Delivered to You Automatically Sign up to receive the latest news and ratings for CDXS and its competitors with MarketBeat's FREE daily newsletter. Email Address The AI Bottleneck No One is Talking About (Ad)Renewable energy is growing at an impressive speed - but not fast enough. This could be one of the greatest periods for the nuclear industry ever. Click here to see who's preparing to meet these needs CDXS Media Mentions By Week CDXS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CDXS News Sentiment▼1.710.63▲Average Medical News Sentiment CDXS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CDXS Articles This Week▼12▲CDXS Articles Average Week Get Codexis News Delivered to You Automatically Sign up to receive the latest news and ratings for CDXS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ANNX News TSVT News CGEN News ME News GLSI News GRTS News TLSI News FF News CDT News AKYA News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CDXS) was last updated on 3/19/2024 by MarketBeat.com Staff From Our Partners8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressCentral Bank Gold Heist In ProgressColonial MetalsLike Tiny Crypto Retirement FundsCrypto 101 MediaThe AI Bottleneck No One is Talking AboutThe Bull ReportMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThe world’s greatest investmentPorter & CompanyBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Codexis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.